Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS / Acquisitions / Apogee Therapeutics, Inc.

M&Awas acquired (SEC 8-K)3 Sept 2026

Apogee Therapeutics, Inc.

3 Sept 2026: Was acquired (SEC 8-K) · Pharma and biotech. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
3 Sept 2026
Ticker
APGE
Role
Was acquired
Sector
Pharma and biotech
Sic
2836
Items
1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Summary
As previously disclosed, on June 18, 2026, Apogee Therapeutics, Inc., a Delaware corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Andor LLC, a Delaware limited liability company and a wholly owned subsidiary of Guarantor ("Parent"), Andor Merger Co., a Delaware corp
Location
San Francisco, CA
State
California
Country
United States
SEC CIK
1974640
Reference
0001140361-26-035537
What this signal means

Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.

  1. Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
  2. 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Apogee Therapeutics, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.

Start free

More in Was acquired

Acquisitions

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.